Abstract
Out-of-office BP measurements, ambulatory BP monitoring (ABPM), and self-BP measurement play an important role in the evaluation of resistant hypertension. In fact 24 h ABPM has been considered mandatory at the time to evaluate resistant hypertension from the beginning of clinical use. Furthermore, clinical research has expanded the potential role of out-of-office measurements not only to the initial evaluation of resistant hypertension but also to refine cardiovascular and renal risk stratification and for a better follow-up. The widespread use of self-BP measurement at home introduced a new tool to properly assess out-of-office BP, and it has also been recommended in these patients although the potential differences between the two methods remain controversial.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Calhoun DA, Jones D, Textor S, American Heart Association Professional Education Committee et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117:e510–e526
Moser M, Setaro JF (2006) Resistant or difficult-to-control hypertension. N Engl J Med 355:385–392
Oikawa T, Obara T, Ohkubo T, J-HOME Study Group et al (2006) Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 24:1737–1743
Parker MG (2008) Resistant hypertension: core curriculum 2008. Am J Kidney Dis 52:796–802
Bunker J, Callister W, Chang CL et al (2011) How common is true resistant hypertension? J Hum Hypertens 25:137–140
Mancia G, de Backer G, Dominiczak A, Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology et al (2007) Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187
Chobanian AV, Bakris GL, Black HR, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252
Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension 57:1076–1080
Daugherty SL, Powers JD, Magid DJ et al (2012) Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 125:1635–1642
Massierer D, Oliveira AC, Steinhorst AM et al (2012) Prevalence of resistant hypertension in non-elderly adults: prospective study in a clinical setting. Arq Bras Cardiol 99:630–635
Pedrosa RP, Drager LF, Gonzaga CC et al (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58:811–817
de la Sierra A, Segura J, Banegas JR et al (2011) Clinical features of 8,295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57:898–902
Parati G, Stergiou GS, Asmar R, ESH Working Group on Blood Pressure Monitoring et al (2008) European society of hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference on home blood pressure monitoring. J Hypertens 26:1505–1526
Redon J, Campos C, Narciso ML et al (1998) Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 31:712–718
Pierdomenico SD, Lapenna D, Bucci A et al (2005) Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 18:1422–1428
Salles GF, Cardoso CR, Muxfeldt ES (2008) Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 168:2340–2346
Lurbe E, Redon J, Kesani A et al (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347:797–805
ESCAPE Trial Group, Wühl E, Trivelli A, Picca S et al (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639–1650
Redon J, Oltra R, Rodilla E et al (2001) Prognostic value of repeated ambulatory blood pressure monitoring in refractory hypertension. J Clin Hypertens 13(suppl 1):134–135
Shafi S, Sarac E, Tran H (2012) Ambulatory blood pressure monitoring in patients with chronic kidney disease and resistant hypertension. J Clin Hypertens (Greenwich) 14:611–617
Parikh NI, Hwang SJ, Larson MG et al (2006) Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166:1884–1891
Buckalew VM, Berg RL, Wang SR et al (1996) Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of diet in renal disease study group. Am J Kidney Dis 28:811–821
Fukuda M, Munemura M, Usami T et al (2004) Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorated in nephropathy. Kidney Int 65:621–625
Farmer CK, Goldsmith DJ, Cox J et al (1997) An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant 12:2301–2307
Lurbe E, Redon J (1999) Assessing ambulatory blood pressure in renal diseases: facts and concerns. Nephrol Dial Transplant 14:2564–2568
Redon J, Plancha E, Swift PA et al (2010) Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4. J Hypertens 28:602–607
Muxfeldt ES, Cardoso CR, Salles GF (2009) Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med 169:874–880
Csiky B, Kovaks T, Wagner L et al (1999) Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy. Nephrol Dial Transplant 14:86–90
Timio M, Venanzi S, Lolli S et al (1995) “Non-dipper” hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 43:382–387
Davidson MB, Hix JX, Vidt DG et al (2006) Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med 166:846–852
Nakano S, Ogihara M, Tamura C et al (1999) Reversed circadian blood pressure rhythm independently predicts endstage renal failure in non–insulin-dependent diabetes mellitus subjects. J Diabetes Complications 13:224–231
Redon J, Lurbe E (2002) Ambulatory blood pressure and the kidney: implications for renal dysfunction. In: Epstein M (ed) Calcium antagonists in clinical medicine. Hanley & Belfus, Philadelphia, pp 665–679
Fagard RH, Celis H, Thijs L et al (2008) Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55–61
Agarwal R, Light RP (2009) GFR, proteinuria and circadian blood pressure. Nephrol Dial Transplant 24:2400–2406
Muxfeldt ES, Cardoso CR, Dias VB et al (2010) Prognostic impact of the ambulatory arterial stiffness index in resistant hypertension. J Hypertens 28:1547–1553
Clark D 3rd, Ahmed MI, Calhoun DA (2012) Resistant hypertension and aldosterone: an update. Can J Cardiol 28:318–325
Martins LC, Conceição FL, Muxfeldt ES et al (2012) Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension. J Hypertens 30:967–973
Václavík J, Sedlák R, Plachy M et al (2011) Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Hypertension 57:1069–1075
Zelinka T, Pacák K, Widimský J Jr (2006) Characteristics of blood pressure in pheochromocytoma. Ann N Y Acad Sci 1073:86–93
Muxfeldt ES, Fiszman R, de Souza F et al (2012) Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension. Hypertension 59:384–389
Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275–1281
Simplicity Trial Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911–917
Esler MD, Krum H, Sobotka PA et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial. Lancet 376:1903–1909
Doumas M, Anyfanti P, Bakris G (2012) Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens 30:874–876
Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J et al (2006) Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129:1459–1467
Lozano L, Tovar JL, Sampol G et al (2010) Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28:2161–2168
Marui FR, Bombig MT, Francisco YA et al (2010) Assessment of resistant hypertension with home blood pressure monitoring. Arq Bras Cardiol 95:536–540
Nasothimiou EG, Tzamouranis D, Roussias LG et al (2011) Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension. J Hum Hypertens Nov 11 Epub ahead of print
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Redon, J., Martinez, F. (2013). 24-hour Ambulatory BP Monitoring and Home BP Measurements in Resistant Hypertension. In: Mancia, G. (eds) Resistant Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-5415-8_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-5415-8_8
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5414-1
Online ISBN: 978-88-470-5415-8
eBook Packages: MedicineMedicine (R0)